Compliance with nCPAP in elderly patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 569s Year: 2004
Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 97s Year: 2003
Daytime hypercapnia in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 493s Year: 2002
CPAP variability in long term follow-up of OSAS (obstructive sleep apnea syndrome) patients Source: Eur Respir J 2006; 28: Suppl. 50, 412s Year: 2006
The effect of theophylline and CPAP on cytokine release in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 216s Year: 2006
Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009
The frequency of rhinitis in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea Year: 2008
CPAP therapy improves endothelial dysfunction in obstructive sleep apnea hypopnea syndrome (OSAHS) Source: Eur Respir J 2004; 24: Suppl. 48, 565s Year: 2004
Fibrinogen level in patients with severe obstructive sleep apnoea syndrome (OSAS). Effect of n-CPAP therapy Source: Eur Respir J 2001; 18: Suppl. 33, 216s Year: 2001
Does personality change in obstructive sleep apnea (OSA) patients using CPAP? Source: Eur Respir J 2006; 28: Suppl. 50, 409s Year: 2006
Compliance with CPAP/BiPAP treatment in obstructive sleep apnea syndrome patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010
Residual sleepiness in obstructive sleep apnea (OSA) patients on CPAP: Not only a symptom but rather a true syndrome? Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012
Secondary hypogonadism induced by severe obstructive sleep apnea syndrome (OSAS) and results after two months CPAP treatment Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010
CPAP and uvulopalatopharyngoplasty (UPPP) normalized pulmonary hypertension in patients with obstructive sleep apnea (OSAS) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007
The clinical significance nocturnal hypoventilation (NH) in patients with severe obstructive sleep apnoea (OSA) Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020
Cardiohemodynamics parameters in patients with COPD and obstructive sleep apnea, (OSA). Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea Year: 2017
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010
Prevalence of complex sleep apnea (CompSAS) during manual CPAP titration for obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009
CPAP induces structural changes in the inspiratory muscles of patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 222s Year: 2002
Masked hypertension and obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 416s Year: 2006